Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12227504
Spirocyclic compounds
granted -
US 12226491
Nano-satellite complexes
granted -
US 12226524
Coated implants for long-term controlled release of antibody therapeutics
granted -
US 12226490
Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates preliminary class
granted -
US 12226474
Methods and compositions for treating infections
granted -
US 12226455
Medical composition for treating cardiac wasting and cachexia
granted -
US 12226444
Compositions comprising peptides comprising variant kinesin light chain 1 and cell-penetrating peptides
granted -
US 12226456
Nasal powder formulation for treatment of hypoglycemia
granted -
US 12226437
Method for enhancing expression of insulin like growth factor 1 receptor in umbilical cord mesenchymal stem cell expressing IGF1R and method for obtaining multipotent umbilical cord mesenchymal stem cell
granted -
US 12226489
Compounds and methods for treating gastrointestinal disease
granted -
US 12227479
Dihydropyridines for the treatment of cognitive impairment or traumatic brain injury
granted -
US 12227554
Methods for selectively expanding cells expressing a TCR with a murine constant region
granted -
US 12226610
Treatment of pain associated with total knee arthroplasty with sustained-release liposomal anesthetic compositions
granted -
US 12227581
Anti-BCMA single domain antibodies and application thereof
granted -
US 12227584
Multivalent and multispecific OX40-binding fusion proteins
granted -
US 12227740
CBLB endonuclease variants, compositions, and methods of use
granted -
US 2025049789
METHODS OF TREATING ALOPECIA ARAETA
granted -
US 12220447
Proteolytic enzyme composition
granted -
US 12221610
RNAi agents for inhibiting expression of HIF-2 alpha (EPAS1), compositions thereof, and methods of use
granted -
US 12221463
Method of promoting wound healing by inhibiting CCR3
granted -
US 12221627
Methods of enriching cell populations for cancer-specific T cells using in vitro stimulation of memory T cells
granted -
US 12221622
Modified pluripotent cells
granted -
US 12221483
Fusion protein and nucleic acid encoding sequence thereof, and uses of the same
granted -
US 12221441
Plasma kallikrein inhibitors and uses thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.